These findings not only define a novel epitranscriptomic–lncRNA regulatory mechanism in ferroptosis but also posit that the METTL3/lncRNA-AU020206/YTHDC2/SLC7A11 axis is a promising target for therapeutic intervention in ischemic stroke (Figure 7). Here, METTL3 is linked to ischemic stroke.